Topical Medication Therapy for Glaucoma and Ocular Hypertension

por Tao Wang, Linlin Cao, Qikun Jiang, Tianhong Zhang
Publicado 2021

Dexamethasone/Netilmicin Eye Drops and Eye Gel for the Treatment of Ocular Inflammation After Micro-Incisional Vitreoretinal Surgery

por Rapisarda A, Arpa P, Fantaguzzi PM, Faraldi F, Ratiglia R, Rizzo S, Vaona P, Iannacone C, Papa V
Publicado 2020

Short-Term Use of Dexamethasone/Netilmicin Fixed Combination in Controlling Ocular Inflammation After Uncomplicated Cataract Surgery

por Caporossi A, Alessio G, Fasce F, Marchini G, Rapisarda A, Papa V
Publicado 2021

Efficacy of the travoprost/timolol fixed combination versus the concomitant use of travoprost 0.004% and timolol 0.1% gel formulation

por Kozobolis V, Konstantinidis A, Sideroudi H, Teus M
Publicado 2018

Possibilities of application a fixed combination of alogliptin and pioglitazone for type 2 diabetes mellitus treatment

por M. V. Shestakova, M. B. Antsiferov, A. S. Ametov, G. R. Galstyan, T. Y. Demidova, A. M. Mkrtumyan, N. A. Petunina
Publicado 2021

Switching from concomitant therapy to tafluprost/timolol fixed combination

por Inoue K, Kawashima T, Katakura S, Shidara K, Fujimoto T, Kohmoto H, Shiokawa M, Moriyama R, Okayama R
Publicado 2018

Preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% in patients with open-angle glaucoma and ocular hypertension: results of an open-label observational stud...

por Pillunat LE, Erb C, Ropo A, Kimmich F, Pfeiffer N
Publicado 2017

Fixed-Combination Eye Drops Based on Fluorometholone Nanoparticles and Bromfenac/Levofloxacin Solution Improve Drug Corneal Penetration

por Otake H, Goto R, Ogata F, Isaka T, Kawasaki N, Kobayakawa S, Matsunaga T, Nagai N
Publicado 2021

The signs of ocular-surface disorders after switching from latanoprost to tafluprost/timolol fixed combination: a prospective study

por Okumichi H, Kiuchi Y, Baba T, Kanamoto T, Naito T, Nakakura S, Tabuchi H, Nii H, Sueoka C, Sugimoto Y
Publicado 2017

Fixed combination of travoprost and timolol maleate reduces intraocular pressure in Japanese patients with primary open-angle glaucoma or ocular hypertension: analysis by prostagla...

por Nakano T, Mizoue S, Fuse N, Iwase A, Matsumoto S, Yoshikawa K
Publicado 2016

Preservative-free bimatoprost 0.03%/timolol 0.5% fixed combination in patients with glaucoma in clinical practice

por Pfennigsdorf S, Eschstruth P, Häsemeyer S, Feuerhake C, Brief G, Grobeiu I, Shirlaw A
Publicado 2016

The place of fixed antihypertensive drugs in modern therapy of arterial hypertension

por Tatiana V. Pinchuk, Natalia V. Orlova
Publicado 2021

First results of Russian multicenter prospective clinical study VICTORY II: Vamloset® and Co-Vamloset effectiveness and safety in patients with stage 2 and 3 arterial hypertension

por I. E. Chazova, T. V. Martynyuk, V. O. Rodnenkov, B. Sh. Gorieva, A. N. Rogoza, M. V. Arkhipov, Yu. I. Grinshtein, O. D. Ostroumova, A. S. Galiavich, O. P. Rotar’, L. A. Haisheva, T. R. Kameneva
Publicado 2020

Implementation of the organoprotective properties of fixed combinations of valsartan, amlodipine and hydrochlorothiazide (Vamloset® and Co-Vamloset) in patients with grade 2 and 3...

por Irina E. Chazova, Tamila V. Martynyuk, Oleg V. Rodnenkov, Shurat B. Gorieva, Anatolii N. Rogoza, Mikhail V. Arkhipov, Yury I. Grinshtein, Olga D. Ostroumova, Albert S. Galiavich, Oxana P. Rotar’, Larisa A. Khaisheva, Tatiana R. Kameneva
Publicado 2020